visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Poseida Therapeutics, Inc.

    Get Full Access

    Description

    • Poseida Therapeutics, Inc. is currently developing CAR-T and gene therapy products for cancer and orphan diseases. Spinout of Transposagen Biopharmaceuticals early this year, Poseida is also collaborating with J&Js Janssen to develop allogeneic CAR-T therapies against cancer. Poseida boasts best-in-class genome engineering capabilities for effectively silencing target genes or inserting therapeutic genes and/or technologies. Proprietary tools include piggyBac DNA Modification System, NextGEN CRISPR, XTN TALEN and Footprint-Free Gene Editing System, which are clean (synthetic and virus-free) and can be surgically precise. Poseida aims to shuttle the first CAR-T and gene therapy product candidates into Phase I clinical trials in early 2017. Poseida is now hiring and searching for ambitious and motivated scientists desiring a fast-paced work environment with diverse research opportunities in the field of cellular and gene therapy.
    • location

      Headquarters:9390 Towne Centre Drive , San Diego, California, United States

      More
    • Poseida Therapeutics, Inc. phone

      Phone Number: +1 858-779-3100

    • Poseida Therapeutics, Inc. website

      Website: https://www.poseida.com

    • Poseida Therapeutics, Inc. employees

      Employees:175

    • Poseida Therapeutics, Inc. revenue

      Revenue:$100 - 250M

    • Poseida Therapeutics, Inc. legal name

      Legal Name:Poseida Therapeutics, Inc.

    • Poseida Therapeutics, Inc.'s Social Media

      Poseida Therapeutics, Inc. linkedin Poseida Therapeutics, Inc. twitter
    • done Is this data correct?

    • |  NAICS Code: 541713  |

      Show More
    Person level website identification

    CEO for Poseida Therapeutics, Inc.

    Mark Gergen

    Chief Executive Officer And Director

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Matthew Spear

    Chief Medical Officer

    Devon Shedlock

    Chief Scientific Officer, Cell Therapies

    Johanna Mylet

    Chief Financial Officer

    Joshua Rychak

    Vice President, In Vivo Gene Therapy

    Karen Basbaum

    Vice President, Business Development

    Frequently Asked Questions regarding Poseida Therapeutics, Inc.

    • Where are Poseida Therapeutics, Inc.'s Headquarters?

      Poseida Therapeutics, Inc.'s Headquarters are in 9390 Towne Centre Drive ,San Diego,California,United States

    • What is Poseida Therapeutics, Inc.'s phone number?

      Poseida Therapeutics, Inc.'s phone number is +1 858-779-3100

    • What is Poseida Therapeutics, Inc.'s official website?

      Poseida Therapeutics, Inc.'s official website is https://www.poseida.com

    • What is Poseida Therapeutics, Inc.'s Revenue?

      Poseida Therapeutics, Inc.'s revenue is $100 - 250M

    • What is Poseida Therapeutics, Inc.'s NAICS code?

      Poseida Therapeutics, Inc.'s NAICS code is 541713

    • How many employees are working in Poseida Therapeutics, Inc.

      Poseida Therapeutics, Inc. has 175 employees

    • What is Poseida Therapeutics, Inc.'s Industry?

      Poseida Therapeutics, Inc. is in the industry of Biotechnology

    • Who is Poseida Therapeutics, Inc.'s CEO?

      Poseida Therapeutics, Inc.'s CEO is Mark Gergen

    Company Directory